These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8079725)

  • 21. Pathology of human-mouse somatic cell hybrid tumors.
    Aden DP; Putong P; Iwasaki Y
    J Natl Cancer Inst; 1977 Oct; 59(4):1243-9. PubMed ID: 198557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different growth rates of lung tumours in man and their xenografts in nude mice.
    Mattern J; Wayss K; Haag D; Toomes H; Volm M
    Eur J Cancer (1965); 1980 Feb; 16(2):289-91. PubMed ID: 7371684
    [No Abstract]   [Full Text] [Related]  

  • 23. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
    Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
    J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of proliferation activities in human tumor models: a comparison of flow cytometric methods.
    Keng PC; Siemann DW
    Radiat Oncol Investig; 1998; 6(3):120-7. PubMed ID: 9652910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of telomerase activity and malignant phenotype in multistage carcinogenesis of esophageal epithelial cells induced by human papillomavirus.
    Shen ZY; Xu LY; Li C; Cai WJ; Shen J; Chen JY; Zeng Y
    Int J Mol Med; 2001 Dec; 8(6):633-9. PubMed ID: 11712078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor suppression by p21WAF1.
    Chen YQ; Cipriano SC; Arenkiel JM; Miller FR
    Cancer Res; 1995 Oct; 55(20):4536-9. PubMed ID: 7553623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of cell cycle regulatory protein expression and suppression of tumor growth by mimosine in nude mice.
    Chang HC; Weng CF; Yen MH; Chuang LY; Hung WC
    Int J Oncol; 2000 Oct; 17(4):659-65. PubMed ID: 10995875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice.
    Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Ruka W; Suit HD
    Cancer Res; 1993 Oct; 53(20):5012-7. PubMed ID: 8402692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathologic evaluation of response to treatment of human tumors grown in the nude mouse.
    Kyriazis AA; Kyriazis AP; Kereiakes JG; Soloway MS; McCombs WB
    Exp Cell Biol; 1983; 51(2):83-95. PubMed ID: 6840388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-invasive assessment of tumor oxygenation status by integrated 31P NMR spectroscopy and 1H NMR imaging.
    Rofstad EK; Lyng H; Olsen DR; Steinsland E
    Adv Exp Med Biol; 1994; 345():531-8. PubMed ID: 8079755
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110RB, the retinoblastoma tumor suppressor protein.
    Antelman D; Machemer T; Huyghe BG; Shepard HM; Maneval D; Johnson DE
    Oncogene; 1995 Feb; 10(4):697-704. PubMed ID: 7862447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA; Motwani M; Zakian KL; Li XK; Matei C; Dyke JP; Ballon D; Yoo HH; Schwartz GK
    Clin Cancer Res; 2000 Apr; 6(4):1498-507. PubMed ID: 10778982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.
    Bauer JA; Morrison BH; Grane RW; Jacobs BS; Borden EC; Lindner DJ
    J Interferon Cytokine Res; 2003 Jan; 23(1):3-10. PubMed ID: 12639293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New approaches in experimental cancerology: in search of therapeutic models].
    Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
    Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
    [No Abstract]   [Full Text] [Related]  

  • 37. Regional growth differences of human tumour xenografts in nude mice.
    Dipersio LP
    Lab Anim; 1981 Apr; 15(2):179-80. PubMed ID: 7278124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of prolyl-hydroxylase-1 (PHD1/EGLN2) suppresses hypoxia inducible factor-1alpha activation and inhibits tumor growth.
    Erez N; Milyavsky M; Eilam R; Shats I; Goldfinger N; Rotter V
    Cancer Res; 2003 Dec; 63(24):8777-83. PubMed ID: 14695194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of a Chinese hamster fibroblast mutant defective in hexose transport and aerobic glycolysis: its use to dissect the malignant phenotype.
    Pouysségur J; Franchi A; Salomon JC; Silvestre P
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2698-701. PubMed ID: 6930659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between oxygen and glucose consumption by transplanted tumors in vivo.
    Gullino PM; Grantham FH; Courtney AH; Losonczy I
    Cancer Res; 1967 Jun; 27(6):1041-52. PubMed ID: 4290858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.